Blockade of the platelet glycoprotein IIb/IIIa receptor reduces infarct size in a canine model of myocardial infarction and reperfusion  by Kingma, J.G. et al.
JACC Fehmao' Iq98 AIRSTRACT,~ • P~,~t~r 135A 
Conclusion: Data lno~ate thai infnflatc neural cholinerg~¢ I~lhways, inter, 
acting with cardiac tissue kallikmlrl-kinle ltyslem, canter 8n impe~lant auloreg. 
ulafory mechanism, involved in m~tating the ischem~ myocar~al adaptive 
procesS, 
11056-111 I Sloelmde of the Plat~l~t Oltmoprotain 
' ' Reeepler Reduce= Inf~m SIN In a ~nlne Model 
of l~Fwamlkll I n ~ l o n  and I~peduslon 
J,G Kleg~,  Jr,, S, Ranis, Po Bogaly,/.a~t Ungainly an# OuN~ec Heart 
~mme, S ~  G,d~x~, C m  
I~lCt~r01/t~; Plat¢lot gly¢opr0tei/tt I!b/ltl8 me'ephor (OP!ll~,qlla) bl0¢k~e ahows 
p ~ X ~  in Itt~ t!~k~lMle~ of acuto co~.,~a~ ~/ f~fom~ p~umat~y dge fo lfta, 
b~lization of ~ %'~9M" cOe0~ey 101~lUe, We m ~ l e d  whal~er M K . ~  
~ An~i~hetize~ o ~  do~ls u ~  ! h ~ W  oc- 
dus~r~ foftow~ ~ 3 h ,,~,~,t~n. The~ ~ (Stgm~p) were ~ ;  
! - h e t ~  (HEP; 100 g~ l~ ) ,  ~MK ~r HEP ax~ 3~MK, MK wa~ gwen tV at 
~ ~ ~ m n  (~;!0 .g/Ko ove~ 3 mat fo,'lowe¢l by 3 . ~ K ~  foe 3 h), 
Collateral blood fl0w (aF; mlJm~g) was measured al 30 mm of o c c l ~  
(u=ng mm~zpttm~), ~ (I) was ~ u=ng ~lraz~hwn st=ring 
and ~ i z ~ d  to area at mk lAIR; Moaastral blue dye), 
F~,m~S- C o ~  hemodynam~, BF and AR (mean ± SEM) did nol 
differ I:~l~e~m ~ ;  in dogs ~ MK alone. I ~  ~!atmn b e ~ n  BF and 
iofa¢l size was shifted ~ r d  (Ip = 0003 vs. HEP. ANCOVA) indicating 
can:liopmtectton. 
Coaate~zd I~  AR tc-~l UAR 1%) 
HEP 004±O01  4 8 3 ¢ 1 5  28.8¢3.8 
MK* HEP 0.08 ± 003 458¢2 .3  23.0±2.5 
IdK 0 0~ :t. 0.02 4 8 0 ± 2 7  14.4¢1955 
Conctm~ons: GPIIMIla blockade s~uficantty reduced t~'ue nesmsrs. 
These dat~ doc.m~"tt an additional mechanism of benefit for anti-l~lalelel 
aggregatin9 agents in acute corona w syndromes. 
~ Serum Profi les o f  Pmin f lammatory  Cytokines 
and Their SOluble Receptors According to the 
Severi ty o f  Acute M~ : :a rd l a l  Infarct ion 
J. Panss~S, K~ Ve~etsanou, D. Menlzikol, N Zims, K. Merkouns, C. Kefalas. 
S. Karas. Amalia Fleming Hos~tal and St. Anargm Hospital, Athens. Greece 
Background: Cytokines am known tO regulate the mflammalo~/ and sub- 
sequent proliferative responses o1 patients wdh acule myocardial intarctmn 
(AMI). This sludy investigales the I~netics of prolnftammafon/cytolunes, such 
as lntedeukin-6 ([L-6) and Tumor Necrosis Factor-a (TNF-a), and their so~u- 
hie receptors in pagents with AMI m relation to the seventy of the disease. 
MethoO~: Setrum concentrallons Of IL-6. TNF-a. soluble IL-6 m~,;~p;o¢ 
(sIL-6R) and soluble TNF receptor t (sTNFRI) were delerm~rted in 31 AMI 
patients (20 men and 11 women; age: 37-75 years) w~heut present tuslo~ of 
infection or malignancy by enzyme linkend immunosodaent aasay during the 
first week of hospitalization. Patients of group A (n = 16) had uncanceled 
AMI (Killip class 1) while patients ol group B (n = 15) had severe AMI (Killip 
class >_2). Finally, 10 age-matched volunteers were used as healthy controls. 
Result&" Peaks of IL-6 and slL-6R levels ware not sigrMicantty different 
between the two groups ilL-6: group B 25.2 ± 4.7 vs group A 23 ± 4.3 I ~ 1  
and slL-6R: group B 3.6 • 0.3 vs group A 3.9 • 0 6 noJml, p = NS) but ware 
signi{~cantty higher than the respectnm levels of healthy controls ilL-6:3.9 ± 
0.5 pojmh p < 0.01; slL-6R: 1.7 ~: 0.3 ng/ml, p < 0.05). Furthermore, peaks of 
TNF-a and sTNFRI levels were signil¢.antly higher in group B than respective 
peaks ot cylokine levels in group A (TNF-a: group B 19.2 :~ 3.7 vs group A 
6.2 :~ 1.7 pg/ml, p < 0.01; sTNFRI: group B 4.1 ~ 1.1 vs group A 2.9 ± 0.6 
ng/ml, p < 0.01) and healthy controls (TNF-a: 3.5 • 1.1 Wml and sTNFRI: 
1.9 • 0.1 ng/ml, p -~ 0.001). In group B regression analysis revealed that the 
peak of TNF-a levels significantly correlated with peak of sTNFRI levels (r = 
0.60, p < 0.01), white blood cell counts (r = 0.50, p ~ 0.05), peak of serum 
CK MB isoenzyme (r = 0.67, p ,~ 0.01) and ejec,=on fra,.'tmn (r = -0.61, p - 
0.01). In the same patients, the peak ol sTNFRt lev=ls was also significantly 
correlated with white blood cell counts (r = 0.60, p ~- 0.01), peak o1 serum 
CK MB isoenzyme (r = 0.63, p < 0.01) and ejection fraction (r = -0 .65,  p < 
0.01). Finally, in group B, non survivors (n = 4) had significantly higher peaks 
of TNF-a and sTNFRI levels (both p < 0.05) than those of survivors (n = 11). 
Conclusions: These results suggest that proinflammafory cytokine serum 
activity increases substantially in the two catergories of AMI and TNF-a is a 
major cytokine which may be especially implicated in the pathophysiology of 
severe AMI. This cytokine and its soluble receptor closely correlated with AMI 
severity anci worsening prognosis and may be used as alternative prognostic 
indicators of severe AML 
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~ .mound :  P a ~ t ~  w~h acute m y o c a ~  mtaect~pe (AMI) comlp~te~ 
by card~ogen¢ aback (CGS) have= d~mm=~ mmea~y p a ~  pe~,surs 
wh~h may lira4 I ~  e ~  ot ~l~ysNwl~y I~rl~nlstered t h ~  
balloon countaq~ulsation (!ABP) Is assooaled wrth m~l~OVed smvival in auch 
Method: Using data from ft~e Nalmnal Regml~y o1 Myeeam'tal thfamlmn 
2. we Klentltied 21,711~ p a ~  with AMI who ~ with of developed 
CGS wh~e m hosptaL 
Resu~: Of Ihe 21,178 patients RlentWted, 6,993 (3~,~) ~ IABP 
Pabents who ~ IABP were ~ (66.6 vs 73.S), morn oflee male 
(60% vS 50%) and i'~,ce as Ulu~y to rece4ve ~ TT of pm~Ify PTCA 
(PPTCA) (56% vs 28%). While IABP was azl~¢zatad ~ a ~ g'ptlo=P 
pdal modalify rate in pabents who mcelved I"I" (69 vs 49, p < 0.001), I t~  
was not obser~d m ~ who ~ PPTCA (44% vs 47%, p = ns). 
Theee f, xllege pars~led after cone~ng fo~ baselme d~ftereeces bmween 
the groupS. 
~ o o  
T I ' +  PP'UC'A PPTCA 
IABP + IABP 
Conc/us~ns: The use of IABP m patients w~h AMI complmated by car- 
dmgen~ shock is associated w~th a ma~ecl reductmn in nmrtalW when used 
m com~natlon with lhrombolylm therapy. ~ r ,  the use of IABP is not 
asse~aled w~h improved survwal m pahems ur~ergomg PPTCA 
I 1057:126', PredictOrS o f  Free Wall Rupture in Acute In,%,rior 
! ! Myoemdm mfamUon 
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J L  L0pe:-Send0n, J.L Delc~n. Hosio~l Genera/"Gragotm Marar'~n °, 
Madr/d. Spa/n 
Background: Left ventncular free wall rupture (FWR) m an infrequent and gen. 
eralty lethal complication of AMI. t.am ~ therapy, advanced age, 
lateral Iocattofl of AMI are clfflical fealures associaled wdh its oo=un, ence, 
The mm of this study is to determine the clinical and eleofrecardiegraph¢ 
prediclors of FWR m acute myocardial klP=K.;;on of inferior focation (IMI), 
Methods: The i ~  arid clinK:at pfeC~ors of F~NR were studflB¢l in 
808 c o n ~  patients (pts) with Q-wave IMI of less man 48 hours of 
evolution admitted from 1991 to 1995 to our CCU. 
Resuffs: Mean age was 64 ~ 12 years, 78% wore men. Repedusion 
treatment was used in 54% o! pts. In-hospital case fatality rate was 12.4% 
in the whole cjn~p. 26 I~s developed FWR (3.2%) whch was lalal m 22 
cases (85%). A multiple logistic regression analysis which also included sex, 
prewouS MI, d_~iabetes, hype[ter, s;o~ and i,_l:~usron ~,~va~/selected age, 
ST segment elevahon in V~-Vs leads on admission ECG and time delay 
from symptom onset to CCU admission as independent predictors o! FWR 
development. ST segment elevation in Vs-V~ leads remained as a predictor 
of FWR when only pts admitted eadier than 24 hours and than 12 hours from 
symptom onset ware considered 
Odds raho 95% CI P 
Vs-V s ST elevation 3.1 1 3.-7 t .0.008 
l~me pelay (per hour) 1 03 1 004-I.07 <0 03 
Age (per year) 104 101-1.08 - 004 
Conclusions: ST ~egment elevation in Vs-V6 leads is a very powerful 
predictor of FWR development in pts with IML Advanced age and a longer 
